Outcome Impact of Different Tranexamic Acid Regimen in Cardiac Surgery With Cardiopulmonary Bypass
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cardiac Surgery
- Homeostasis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The subject will be assigned to either high dose regimen group or low dose regimen group of tranexamic acid in a blinded fashionMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Participants, care provider, investigator and outcomes assessor will be blinded to treatment allocation.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
A face to face visit (review in hospital, or remote video interview via smart phone and social media) is required to screen the occurrence of 30-day rate of the composite endpoints of renal dysfunction, myocardial infarction,stroke, seizure, deep venous thrombosis, pulmonary embolism and all-cause m...
A face to face visit (review in hospital, or remote video interview via smart phone and social media) is required to screen the occurrence of 30-day rate of the composite endpoints of renal dysfunction, myocardial infarction,stroke, seizure, deep venous thrombosis, pulmonary embolism and all-cause mortality, specific examinations are needed to confirm the diagnosis.
Tracking Information
- NCT #
- NCT03782350
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Zhe Zheng, MD Chinese Academy of Medical Sciences, Fuwai Hospital
Get Well Soon